Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-25-025796
Filing Date
2025-12-02
Accepted
2025-12-02 17:24:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 308205
2 GRAPHIC form424b3_001.jpg GRAPHIC 3371
  Complete submission text file 0001493152-25-025796.txt   314333
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-291060 | Film No.: 251544218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)